Trials / Recruiting
RecruitingNCT04204499
Analysis of Screen-detected Lung Cancers' Genomic Traits
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 526 (estimated)
- Sponsor
- University College, London · Academic / Other
- Sex
- All
- Age
- 50 Years – 77 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, observational cohort study of patients undergoing surgical resection for low dose CT (LDCT) screen-detected lung cancer (detected through the SUMMIT study- ClinicalTrials.gov Identifier: NCT03934866/ lung screening programmes), in which translational research is a fundamental aspect.
Detailed description
The ASCENT study seeks to examine the genomic signatures of screen-detected cancers, in order to categorise the biological behaviour of such lesions and correlate this against non-invasive biological and radiological parameters. From these data, the plan is to explore strategies to characterise LDCT-detected cancers through non-invasive means, which the researchers believe may prove key in mitigating potential screening-associated harms.
Conditions
Timeline
- Start date
- 2020-08-10
- Primary completion
- 2025-08-30
- Completion
- 2026-03-30
- First posted
- 2019-12-19
- Last updated
- 2025-07-25
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04204499. Inclusion in this directory is not an endorsement.